Search research articles
Contact Us
Filters
Showing results (441-450 of 577) with videos related to
Page
of 58
Sort By:
Allergy
|
December 21, 2013
IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization
C Uermösi, F Zabel, V Manolova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
Mona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.
Allergy
|
August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic response
Martin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.
The Journal of Experimental Medicine
|
May 19, 1997
Role of repetitive antigen patterns for induction of antibodies against antibodies
T Fehr, M F Bachmann, E Bucher, et al.
The Journal of Experimental Medicine
|
March 3, 1997
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis
T Fehr, G Schoedon, B Odermatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2009
Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles
Susanne A Keller, Caroline E von Allmen, Heather J Hinton, et al.
Immunity
|
July 1, 1996
Duration of TCR stimulation determines costimulatory requirement of T cells
T M Kündig, A Shahinian, K Kawai, et al.
Thrombosis and Haemostasis
|
September 6, 2003
Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2
Christine Piossek, Karl-Heinz Thierauch, Jens Schneider-Mergener, et al.
European Journal of Immunology
|
June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity
Patrik Maurer, Gary T Jennings, Jörg Willers, et al.
Frontiers in Immunology
|
February 27, 2023
Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation
Xinyue Chang, Xuelan Liu, Byron Martina, et al.
Page
of 58
Search research articles
Search
Showing results (441-450 of 577) with videos related to
Sort By:
Page
of 58
Allergy
|
December 21, 2013
IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization
C Uermösi, F Zabel, V Manolova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2017
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
Mona O Mohsen, Ariane C Gomes, Gustavo Cabral-Miranda, et al.
Allergy
|
August 27, 2024
On the role of antibody affinity and avidity in the IgE-mediated allergic response
Martin F Bachmann, Pascal S Krenger, Mona O Mohsen, et al.
The Journal of Experimental Medicine
|
May 19, 1997
Role of repetitive antigen patterns for induction of antibodies against antibodies
T Fehr, M F Bachmann, E Bucher, et al.
The Journal of Experimental Medicine
|
March 3, 1997
Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis
T Fehr, G Schoedon, B Odermatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2009
Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles
Susanne A Keller, Caroline E von Allmen, Heather J Hinton, et al.
Immunity
|
July 1, 1996
Duration of TCR stimulation determines costimulatory requirement of T cells
T M Kündig, A Shahinian, K Kawai, et al.
Thrombosis and Haemostasis
|
September 6, 2003
Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2
Christine Piossek, Karl-Heinz Thierauch, Jens Schneider-Mergener, et al.
European Journal of Immunology
|
June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity
Patrik Maurer, Gary T Jennings, Jörg Willers, et al.
Frontiers in Immunology
|
February 27, 2023
Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation
Xinyue Chang, Xuelan Liu, Byron Martina, et al.
Page
of 58